Here, we discovered that various statins markedly potentiated the cytotoxic activity of CHR2863 in multiple human AML cell lines as well as in CHR2863-resistant cells, by a mechanism that involves perturbation of Rheb prenylation as an essential complementary factor to mTOR inhibition by APis. Here, RHEB is linked to acute myeloid leukemia.